doi:10.1016/bs.vh.2022.01.011 Kumrungsee T, Peipei Z, Yanaka N, Suda T, Kato N
It is important to note that IV Glutathione therapy is not FDA-approved, and the IV infusion is not meant to treat, prevent, or alter any disease process or ailments
Reported Timeline Patterns (Community + Compound-Level) Window Weeks 1-2 What People Often Report Inflammation-related changes
It also influences melatonin production and may reduce basal corticotropin levels
KEY FEATURES GHK-Cu lyophilised research-grade peptide 50mg per vial Independent HPLC-MS verified to 99.76% purity (CoA on public Lab Results portal) Single-batch fill, single-batch chromatogram no blending across lots Synthesised in accredited contract laboratories with full QA paper trail Crimp-sealed, tamper-evident research vial in unbranded outer packaging Dispatched from Australia on Auspost Express with insulated cold-pack option SPECIFICATIONS Product Name GHK-Cu Category Copper Peptides Grade Research grade laboratory use only Quantity 50mg per vial Form Lyophilised powder cake Purity 99.76% verified by HPLC-MS Appearance White to off-white lyophilised solid Storage 28 C lyophilised
Cunneely Anne Roberts Sonia Fargue John Knight Dean G
